2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
199
OTHER
27
UNKNOWN
1
OTHER_GOV
1
NIH
1
FED
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
267
Neoplasms
177
Colorectal Neoplasms
133
Stomach Neoplasms
107
Uterine Cervical Neoplasms
96
Carcinoma, Non-Small-Cell Lung
89
Prostatic Neoplasms
83
Lung Neoplasms
78
Carcinoma, Hepatocellular
73
Rectal Neoplasms
64
Ovarian Neoplasms
54
Esophageal Neoplasms
53
Pancreatic Neoplasms
52
Colonic Neoplasms
52
Recurrence
43
Multiple Myeloma
39
Neoplasm Metastasis
38
Head and Neck Neoplasms
37
Endometrial Neoplasms
36
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Motor Activity
34
Melanoma
33
Polycystic Ovary Syndrome
32
Lymphoma
32
Urinary Bladder Neoplasms
31
Leukemia, Myeloid, Acute
30
Thyroid Neoplasms
29
Small Cell Lung Carcinoma
28
Nasopharyngeal Carcinoma
25
Lymphoma, Non-Hodgkin
25
Interventions
pembrolizumab
1
durvalumab
1
atezolizumab
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled